[go: up one dir, main page]

ES2007544A6 - {RPCEDOMIENTO TO PREPARE PHARMACEUTICAL PREPARATIONS FOR STIMULATING WOUND HEALING. - Google Patents

{RPCEDOMIENTO TO PREPARE PHARMACEUTICAL PREPARATIONS FOR STIMULATING WOUND HEALING.

Info

Publication number
ES2007544A6
ES2007544A6 ES8802427A ES8802427A ES2007544A6 ES 2007544 A6 ES2007544 A6 ES 2007544A6 ES 8802427 A ES8802427 A ES 8802427A ES 8802427 A ES8802427 A ES 8802427A ES 2007544 A6 ES2007544 A6 ES 2007544A6
Authority
ES
Spain
Prior art keywords
wound healing
rpcedomiento
pharmaceutical preparations
prepare pharmaceutical
stimulating wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8802427A
Other languages
Spanish (es)
Inventor
Janos Balini
Sandor Jancso
Tamas Farago
Janos Erdei
Istvan Kovacs
Nacida Harsy Zsuzsanna Emri
Nacida Lokodi Katalin Horvath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Works PLC
Original Assignee
Biogal Gyogyszergyar Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar Rt filed Critical Biogal Gyogyszergyar Rt
Publication of ES2007544A6 publication Critical patent/ES2007544A6/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/436—Inhibitors, antagonists of receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Pharmaceutical products for promoting wound healing comprise a carrier for covering wounds and injuries having an H-1 and/or H-2 receptor-blocking antihistamine as active ingredient e.g. cimetidine or ranitidine and, if desired, other pharmaceutically acceptable additives. The product is prepared by treating a solid, suitably porous, carrier with a solution containing 0.1 to 50% by weight of the active ingredient.
ES8802427A 1987-08-04 1988-08-03 {RPCEDOMIENTO TO PREPARE PHARMACEUTICAL PREPARATIONS FOR STIMULATING WOUND HEALING. Expired ES2007544A6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU873554A HU201683B (en) 1987-08-04 1987-08-04 Process for producing pharmaceutical compositions for promoting healing of wounds

Publications (1)

Publication Number Publication Date
ES2007544A6 true ES2007544A6 (en) 1989-06-16

Family

ID=10964527

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8802427A Expired ES2007544A6 (en) 1987-08-04 1988-08-03 {RPCEDOMIENTO TO PREPARE PHARMACEUTICAL PREPARATIONS FOR STIMULATING WOUND HEALING.

Country Status (16)

Country Link
JP (1) JPH01117828A (en)
AU (1) AU612387B2 (en)
BE (1) BE1001932A4 (en)
BG (1) BG49522A1 (en)
CH (1) CH675833A5 (en)
CS (1) CS274600B2 (en)
DD (1) DD272414A5 (en)
DE (1) DE3826419A1 (en)
ES (1) ES2007544A6 (en)
FI (1) FI883638A7 (en)
FR (1) FR2619011A1 (en)
GB (1) GB2207865B (en)
HU (1) HU201683B (en)
IT (1) IT1226586B (en)
NL (1) NL8801930A (en)
SE (1) SE8802805L (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1327748C (en) * 1988-09-20 1994-03-15 Christopher William Quirk Pharmaceutical composition containing ranitidine and alginic acid
IT1241521B (en) * 1990-07-31 1994-01-17 Polifarma Spa THEPERAUTIC USE OF RANITIDINE IN THE TREATMENT OF INTERESTING WOUNDS SKIN AND THE UNDERLYING FABRICS
GB9102660D0 (en) * 1991-02-07 1991-03-27 Ultra Lab Ltd Wound dressing materials
DE4220736A1 (en) * 1992-06-25 1994-01-05 Puetter Medice Chem Pharm Inclusion complexes of polymerized cyclodextrins with pharmaceutically active substances
GB9424562D0 (en) * 1994-12-06 1995-01-25 Giltech Ltd Product
DE9420259U1 (en) * 1994-12-17 1995-02-09 Röhm GmbH, 64293 Darmstadt Debittered ranitidine preparation
AR008293A1 (en) * 1996-08-16 1999-12-29 Schering Corp COMPOSITION THAT INCLUDES AN ANTIHISTAMINIC AMOUNT FOR THE TREATMENT OF ALLERGIC RESPONSES OF THE SUPERIOR RESPIRATORY TRACT
US5869479A (en) * 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses
JP2001139477A (en) * 1999-11-17 2001-05-22 Coherent Technology:Kk Tissue cell growth promoting solution at the wound site
WO2003057072A2 (en) 2001-12-31 2003-07-17 Ares Laboratories, Llc Hemostatic compositions and methods for controlling bleeding
DE10355085A1 (en) * 2003-11-24 2005-06-23 Schure, Frank, Dr. wound dressing
CN103816560B (en) * 2014-03-03 2015-06-24 广西南宁博恩康生物科技有限公司 Colloidal fluid used for wound restoration and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE452109B (en) * 1973-01-29 1987-11-16 Pharmacia Ab SCIENTIFIC CLEANER EXTENDED SARYTOR
US4747845A (en) * 1983-10-17 1988-05-31 Enquay Pharmaceutical Associates Synthetic resin matrix system for the extended delivery of drugs
US4668228A (en) * 1985-03-12 1987-05-26 Johnson & Johnson Products, Inc. Debriding tape
IE58373B1 (en) * 1986-06-18 1993-09-08 Bloomfield Frederick Jacob 5-Lipoxygenase pathway inhibitors

Also Published As

Publication number Publication date
DE3826419A1 (en) 1989-02-16
FR2619011A1 (en) 1989-02-10
FI883638L (en) 1989-02-05
HUT47848A (en) 1989-04-28
HU201683B (en) 1990-12-28
SE8802805D0 (en) 1988-08-03
GB8818575D0 (en) 1988-09-07
BG49522A1 (en) 1991-12-16
CS274600B2 (en) 1991-08-13
IT8821634A0 (en) 1988-08-03
NL8801930A (en) 1989-03-01
FI883638A0 (en) 1988-08-03
CS543688A2 (en) 1990-10-12
IT1226586B (en) 1991-01-24
FI883638A7 (en) 1989-02-05
DD272414A5 (en) 1989-10-11
GB2207865A (en) 1989-02-15
CH675833A5 (en) 1990-11-15
BE1001932A4 (en) 1990-04-17
AU2038788A (en) 1989-02-09
JPH01117828A (en) 1989-05-10
GB2207865B (en) 1991-10-09
AU612387B2 (en) 1991-07-11
SE8802805L (en) 1989-02-05

Similar Documents

Publication Publication Date Title
SE8702907D0 (en) STABLE PHARMACEUTICAL PREPARATION CONTAINING GRANULOCYTE COLONY STIMULATING FACTOR AND PROCESS FOR PRODUCING THE SAME
FI886019A7 (en) Patch for controlled delivery of active ingredients to the skin
ES550807A0 (en) A PROCEDURE FOR THE PRODUCTION OF A PHARMACEUTICAL PREPARATION FOR SLOW AND CONTROLLED RELEASE.
ATE163849T1 (en) MEDICINAL PRODUCTS CONTAINING R-ALPHA-LIPOIC ACID OR S-ALPHA-LIPOIC ACID AS THE ACTIVE INGREDIENTS
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
ATE188119T1 (en) REMEDIES FOR WOUNDS AND HEMORRHOIDS
ES2007544A6 (en) {RPCEDOMIENTO TO PREPARE PHARMACEUTICAL PREPARATIONS FOR STIMULATING WOUND HEALING.
MD707C2 (en) Sulphonylurea derivatives, process of their preparation, the intermediate products for them, the herbicide and plants growing suppressing remedy on their base, weeds control process
ATE72238T1 (en) IMIDAZOLIUM SALTS, INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND USE.
SE8001599L (en) TRANSDERMAL MEDICATION SYSTEM FOR ISOSORBID DINITRATE
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
ES2063250T3 (en) USE OF THROMBOSPONDIN TO FACILITATE HEALING OF WOUNDS.
DE19475001I2 (en) Anthelmintic combinations of active ingredients.
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
AU3447284A (en) New cyclic benzenesulfonamides, process for their preparation and their use as active substance of pharmaceutical compositions
NO873934L (en) SPECIAL SEROTONINANTAGONISTIC RELATIONSHIP.
NO893256D0 (en) PROCEDURE FOR THE PREPARATION OF FURYLTIAZOLD DERIVATIVES.
DE68905076D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN Wounds.
FR2567402B1 (en) NOVEL PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING DIHYDROXY-1,8 PHENYL-10 ANTHRONE-9 AS ACTIVE INGREDIENT, AND PROCESS FOR PREPARING THE ACTIVE INGREDIENT
FR2567755B1 (en) NEW ANTI-TUMOR DRUG CONTAINING TRIACETOXY-1,8,9 ANTHRACENE AS ACTIVE INGREDIENT
ATE97574T1 (en) MEDICINAL COMPOSITION CONTAINING DEOXYRIBONUCLEOSIDES FOR HEALING OF WOUNDS.
UA12937A (en) MEDICINAL PRODUCT FOR LOCAL TREATMENT OF GYHYO-INFLAMMATORY PAIN AND BURNS STIFFLATED BY STAFILOCOCCUS
IT7926577A0 (en) PREPARATION FOR THE TREATMENT OF WOUNDS, SORES, ULCERATIONS AND OTHER EXUDATIVE SKIN DISEASES.

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-08-03

FD1A Patent lapsed

Effective date: 20001009